Kiniksa Pharmaceuticals International (KNSA) Other financing activities (2018 - 2020)

Kiniksa Pharmaceuticals International has reported Other financing activities for 3 years, with the latest figure at $160000.0 in Q4 2020.

• For the quarter ending Q4 2020, Other financing activities changed N/A year-over-year to $160000.0; the trailing twelve-month figure through Dec 2020 stood at $567000.0 (up 380.51% YoY), and the FY2020 full-year result was $1.1 million, up 862.71% from the prior year.
• Other financing activities for Q4 2020 stood at $160000.0, down from $407000.0 in the prior quarter.
• The five-year high for Other financing activities was $2.8 million in Q2 2018, with the low at $11000.0 in Q4 2018.
• Historically, Other financing activities has averaged $542750.0 across 3 years, with a median of $130000.0 in 2019.
• The largest YoY upside for Other financing activities was 244.83% in 2019 against a maximum downside of 99.36% in 2019.
• Kiniksa Pharmaceuticals International's Other financing activities stood at $11000.0 in 2018, then jumped by 63.64% to $18000.0 in 2019, then jumped by 788.89% to $160000.0 in 2020.
• The last three Other financing activities figures came in at $160000.0 (Q4 2020), $407000.0 (Q3 2020), and $18000.0 (Q2 2019), per Business Quant data.